Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival

Table 3

Multivariate analysis for overall survival of SOC patients.

Variables	HR	95% CI	value
Age
>60 vs. ≤60 yrs	2.21	1.41-3.46	0.001
Laterality
Bilateral vs. unilateral	1.78	0.999-3.16	0.050
Lymph node status
Positive vs. negative	1.31	0.83-2.07	0.244
FIGO stage
Stage III vs. stage I-II	2.97	1.55-5.67	0.001
Stage IV vs. stage I-II	7.06	2.95-16.91	<0.001
DYRK3 expression
High vs. low	2.60	1.67-4.07	<0.001

Abbreviations: HR: hazard ratio; 95% CI: 95% confidence interval; SOC: serous ovarian cancer; DYRK3: dual-specificity tyrosine phosphorylation-regulated kinase 3; FIGO: International Federation of Gynecology and Obstetrics. Note: data was analyzed by Cox hazard regression test. indicates .